Stay updated on PRS-343 HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRS-343 HER2+ Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T01:03:55.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the previous notices (including the funding-lapse notice and Revision: v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:11:50.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding, stating that information may not be up to date and directing users to cc.nih.gov and opm.gov. Updated page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:20:46.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option on the page and introduced the 'Last Update Submitted that Met QC Criteria' label in the Study Record Dates. Also updated capitalization for 'No FEAR Act Data' and the revision/version reference from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:19:41.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4; no study content changes or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:48:58.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations section updated: a consolidated Locations heading now lists states (Arizona, California, District of Columbia, Maryland, New York, Pennsylvania, Tennessee, Texas) and replaces the prior state-specific 'Locations' subsections (Arizona Locations, California Locations, etc.).
    Difference
    1.0%
    Check dated 2025-12-23T17:12:53.000Z thumbnail image

Stay in the know with updates to PRS-343 HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.